Back to search
FDAFDA · Food and drugs·Recall number D-0150-2025

Dihydroergotamine Mesylate Injection, solution for injection, USP, 1 mg/mL Ampules, Rx Only, Distributed by: Provepharm Inc. 100 Springhouse Drive Suite 105, Collegeville, PA 19426, NDC 81284-411-05

Published December 25, 2024 · Recall initiated: November 22, 2024

Summary

FDA records drug Class II recall D-0150-2025, published December 25, 2024 and initiated November 22, 2024. Recalling firm: Provepharm Inc.; Status: Ongoing; Reported quantity: 2160 packs/5 ampules per pack = 10,800 ampules; Lot: Lot #: F9026F01, F9026F02, Exp. Date 12/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Discoloration

What to do

Voluntary: Firm initiated · Letter

Get an email if DIHYDROERGOTAMINE MESYLATE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
DIHYDROERGOTAMINE MESYLATE
Manufacturer
Provepharm Inc.
Distributor
Nationwide within the United States
UPC
0381284411059
Lot
Lot #: F9026F01, F9026F02, Exp. Date 12/2025
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Dihydroergotamine Mesylate Injection, solution for injection, USP, 1 mg/mL Ampules, Rx Only, Distributed by: Provepharm Inc. 100 Springhouse Drive Suite 105, Collegeville, PA 19426, NDC 81284-411-05 recalled?

Yes. FDA published recall D-0150-2025 on December 25, 2024. Reported hazard: Discoloration

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: DIHYDROERGOTAMINE MESYLATE. UPC: 0381284411059.